KAYLA WOLF: Open Payments
NPI 1578134946 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 23 payments from 8 companies in 2025. Trend: 2023 $123 · 2024 $60 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $170 |
| AstraZeneca Pharmaceuticals LP | 7 | $150 |
| ABBVIE INC. | 2 | $139 |
| Exact Sciences Corporation | 3 | $53 |
| Lilly USA, LLC | 3 | $51 |
| Amgen Inc. | 2 | $35 |
| PFIZER INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Ozempic, QULIPTA, FARXIGA, Cologuard Collection Kit, OTEZLA, MOUNJARO, CALQUENCE, JARDIANCE.
Industry payments across AR — which companies pay providers there.
